Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration Period

Trial Profile

Phase III Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration Period

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 22 May 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Unoprostone (Primary)
  • Indications Retinitis pigmentosa
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors R-Tech Ueno
  • Most Recent Events

    • 28 Jan 2016 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 09 Mar 2015 Based on top-line data from this trial, Sucampo has decided not to continue development of unoprostone and will return all licenses to R-Tech Ueno, according to a media release.
    • 09 Mar 2015 Preliminary top-line results published in R-Tech Ueno media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top